全球生物外科市場-市場規模、佔有率、成長分析：按類型（手術密封劑、黏劑）-產業預測（2023-2030）

Global Biosurgery Market Size, Share, Growth Analysis, By Type(Surgical sealants, adhesives) - Industry Forecast 2023-2030

出版日期: 2023年10月24日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2021年全球生物外科市場規模為138.9億美元，2022年為145.6億美元。預計該市場在預測期內（2023-2030 年）將以 6.9% 的年複合成長率擴張，到 2030 年達到 242.1 億美元。

在手術技術的進步和對微創手術的需求不斷成長的推動下，全球生物外科市場正在經歷顯著的成長和轉型。生物外科涉及使用密封劑、止血劑和軟組織修復材料等生物製品來改善癒合和手術效果。這一成長是由手術數量的增加、慢性病患病率的增加以及高齡化所推動的。此外，儘管嚴格的法規要求和產品成本帶來了挑戰，但個人化醫療的採用和創新生技藥品的開拓正在進一步推動市場擴張。總之，全球生物外科市場為公司開發和商業化先進外科解決方案提供了充滿希望的機會。

全球生物外科市場因微創外科技術的日益普及而顯著提振，利用生物外科產品具有減少創傷、更快恢復和減少疤痕等優點。患者和外科醫生對微創手術的偏好不斷增加，加上創新生物材料和手術密封劑等技術進步，正在推動市場成長。

全球生物外科市場面臨的主要障礙是嚴格的法規條件和新產品漫長的核准程序。適用於生物外科產品的法規要求進行廣泛的測試、臨床試驗，並遵守安全性和有效性標準，導致嚴重的延誤和開發成本的增加。這種複雜的法規環境可能會阻礙製造商創新和推出新產品，而與法規合規和產品開拓相關的高成本可能會阻止小型企業進入市場並減緩市場擴張，這可能是一個障礙。

該報告研究了全球生物外科市場並提供了市場概述，包括按類型和地區分類的趨勢以及參與市場的公司概況。

主要企業簡介
- Johnson & Johnson
- Baxter International Inc.
- Medtronic plc
- Integra LifeSciences Holdings Corporation
- B. Braun Melsungen AG
- Stryker Corporation
- Ethicon, Inc.
- Smith &Nephew plc
- Olympus Corporation
- CR Bard, Inc.
- Zimmer Biomet Holdings, Inc.
- BD
- Atrium Medical Corporation
- Maquet Holding BV &Co. KG
- CryoLife, Inc.
- Johnson Matthey
- CSL Limited
- Biotime, Inc.
- Cohera Medical, Inc.
- Sanofi SA

簡介目錄

Product Code: SQMIG35G2174

Global Biosurgery Market size was valued at USD 13.89 billion in 2021 and is poised to grow from USD 14.56 billion in 2022 to USD 24.21 billion by 2030, growing at a CAGR of 6.9% in the forecast period (2023-2030).

The global biosurgery market is undergoing significant growth and transformation, driven by advancements in surgical techniques and the rising demand for minimally invasive procedures. Biosurgery entails the use of biological products like sealants, hemostatic agents, and soft tissue repair materials to enhance healing and surgical outcomes. This growth is fueled by increasing surgical volumes, a higher prevalence of chronic illnesses, and an aging population. Furthermore, the adoption of personalized medicine and the development of innovative biologics are further boosting market expansion, despite challenges posed by strict regulatory requirements and product costs. In conclusion, the global biosurgery market offers promising opportunities for companies in the development and commercialization of advanced surgical solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the global biosurgery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The global biosurgery market is segmented by type and region. Based on type, the market can be segmented into surgical sealants, adhesives, hemostatic agents, soft tissue patches, and bone graft substitutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers:

Increasing Demand for Minimally Invasive Surgical Procedures

The global biosurgery market is significantly propelled by the rising popularity of minimally invasive surgical techniques, which leverage biosurgery products for their advantages like reduced trauma, quicker recovery, and minimal scarring. This increasing preference among patients and surgeons for minimally invasive procedures, along with technological advancements like innovative biomaterials and surgical sealants, contributes to the market's growth.

Restraints:

Regulatory Requirements and Lengthy Approval Processes for New Products

A key obstacle confronting the global biosurgery market is the stringent regulatory prerequisites and protracted approval procedures for novel products. The regulations governing biosurgery items necessitate extensive testing, clinical trials, and adherence to safety and effectiveness criteria, resulting in substantial delays and elevated development expenses. This intricate regulatory landscape can impede manufacturers from innovating and launching new products, while the considerable expenses linked to regulatory adherence and product development may obstruct the entry of small and medium-sized enterprises into the market, creating a hurdle to market expansion.

Market Trends:

A notable trend in the global biosurgery market is the increasing adoption of minimally invasive surgical approaches, which present numerous benefits such as smaller incisions, reduced scarring, faster recovery, and fewer postoperative complications compared to traditional open surgeries. Consequently, there is a rising need for biosurgical products tailored for minimally invasive procedures, driven by the growing preference among patients and healthcare providers for less invasive treatments with comparable or superior outcomes. In response to this trend, biosurgery market manufacturers are prioritizing the development of innovative products and techniques to meet the escalating demand and improve patient satisfaction.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Biosurgery Market by Type
- Market Overview
- Surgical sealants
- adhesives
- hemostatic agents
- soft tissue patches
- and bone graft substitutes
Global Biosurgery Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Johnson & Johnson (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Baxter International Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Medtronic plc (Ireland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Integra LifeSciences Holdings Corporation (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- B. Braun Melsungen AG (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Stryker Corporation (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Ethicon, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Smith & Nephew plc (United Kingdom)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Olympus Corporation (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- C.R. Bard, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Zimmer Biomet Holdings, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- BD (Becton, Dickinson and Company) (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Atrium Medical Corporation (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Maquet Holding B.V. & Co. KG (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CryoLife, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Johnson Matthey (United Kingdom)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CSL Limited (Australia)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Biotime, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Cohera Medical, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sanofi S.A. (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments